Development of disseminated superficial porokeratosis in a patient with complicated acute pancreatitis
Published Web Locationhttps://doi.org/10.5070/D39410j0mf
Development of disseminated superficial porokeratosis in a patient with complicated acute pancreatitis1. Department of Dermatology and Venereology, Hospital de São João EPE, Porto, Portugal
O Ferreira1,2, AF Duarte1,2, T Baudrier1, A Mota1,2, F Azevedo1
Dermatology Online Journal 17 (3): 5
2. Faculty of Medicine of Porto, Porto, Portugal
Porokeratosis is a group of hereditary or acquired diseases with abnormal epidermal keratinization. A 71-year-old man was admitted to the Surgery Department after an attack of acute pancreatitis complicated with pancreatic necrosis, which required surgical resection. Three weeks after the admission, the patient was observed by our Dermatology department with sudden onset of a generalized eruption of asymptomatic flat papules with a hyperkeratotic rim, sparing the face, palms, soles, and mucous membranes. A skin biopsy was performed at the border of a leg lesion, which disclosed the presence of cornoid lamella, confirming the clinical diagnosis of disseminated superficial porokeratosis (DSP). The skin eruption spontaneously subsided about one month after pancreatic resection. The late onset of DSP in our patient may represent a type of immunossuppression-induced porokeratosis. Possibly, the pathologic clone of keratinocytes for porokeratosis was present, but remained latent until there was a decrease in the immunological status. It is possible that this relative and transient state of immunossupression was the result of the concurrent necrotizing pancreatitis. This case represents an unusually good outcome of DSP. To the authors best knowledge, this is the first case of DSP related to severe acute pancreatitis.
Porokeratosis is a group of hereditary or acquired diseases with abnormal epidermal keratinization [1, 2]. Clinically, the condition is characterized by annular or gyrate papules and plaques, with central atrophy and sharply elevated hyperkeratotic borders. The typical histologic hallmark is the cornoid lamella. There are six clinical variants described, including Mibelli or plaque type, disseminated superficial, disseminated superficial actinic, linear, punctuate, and palmaris et plantaris disseminata. Recently some reports of disseminated superficial porokeratosis (DSP) have been described in association with immunossuppression.
|Figure 1||Figure 2|
A 71-year-old man was admitted to the Surgery Department because of acute pancreatitis complicated with pancreatic necrosis, which required surgical resection. Three weeks after admission the patient was observed by our Dermatology department because of the sudden onset of a generalized eruption of asymptomatic thin papules with a hyperkeratotic rim, sparing the face, palms, soles, and mucous membranes (Figures 1 through 3). A history of similar skin changes in his family or of excessive sun exposure was denied. A skin biopsy was performed at the border of a leg lesion, which disclosed the presence of a cornoid lamella, confirming the clinical diagnosis of DSP (Figure 4). The skin eruption spontaneously subsided about one month after pancreatic resection (Figure 5).
|Figure 4||Figure 5|
Porokeratosis is an uncommon disorder of unknown etiology. Nevertheless, in patients with a genetic predisposition it is possible that external triggering factors can activate an abnormal clone of epidermal keratinocytes. In this setting several predisposing conditions have been reported, namely bacterial and viral infections (group A streptococcus, herpes simplex virus, HIV), autoimmune diseases (dermatomyositis, Sjögren syndrome, rheumatoid arthritis), inflammatory bowel disease, organ transplantation, lymphoproliferative disorders, and solid malignant tumors (ovarian and colon cancer, cholangiocarcinoma) [1-6]. Although the mechanism of dissemination of porokeratosis remains unclear, several hypotheses have been proposed. For instance, the overexpression of the p53 gene has been implicated in the pathogenesis of porokeratosis associated with malignant solid organ tumors . In the case of infections, autoimmune or inflammatory diseases, an immunological impairment is the most commonly proposed mechanism, In fact, the late onset of DSP in our patient may represent a type of immunossuppression-induced porokeratosis. The pathologic clone of keratinocytes for porokeratosis was present, but remained latent until there was a decrease in the immunological status. It is possible that this relative and transient state of immunossuppression was the result of the concurrent necrotizing pancreatitis in a elderly patient, sufficient enough to trigger the porokeratosis, which resolved upon improvement of the overall patient condition after the surgery. In the light of this view it is interesting that Ueda et al described in a series of patients significant immunological alterations occurring in the course of severe acute pancreatitis .
The treatment of DSP must be individualized, based on the number and size of the lesions, anatomical location, aesthetic considerations and patient preference. Although there are multiple treatments available, usually the response of porokeratosis to therapy is poor and the disease progresses. Occasional success has been reported with topical corticosteroids, retinoids, 5-fluorouracil (5-FU), imiquimod, vitamin D3 analogues, cryotherapy, and laser [5, 8]. Recently, a case of success was described with the aggressive combination of topical imiquimod and 5-FU . Interestingly, in our patient no treatment was needed thanks to the spontaneous regression after the resection of the necrotic pancreas, which supports the hypothesis that necrotizing pancreatitis was the triggering event. Similarly Cannavó et al reported an unusual regression of an ovarian cancer-related porokeratosis after initiating the chemotherapy .
In conclusion, this case represents an unusually good outcome of DSP. To the authors’ best knowledge this is the first case of DSP related to severe acute pancreatitis.
References1. Cannavó SP, Borgia F, Adamo B, Guarneri B. Simultaneous development and parallel course of disseminated superficial porokeratosis and ovarian cancer: Coincidental association or true paraneoplastic syndrome? J Am Acad Dermatol. 2008; 58(4):657-60. [PubMed]
2. Jung JY, Yeon JH, Ryu HS, Youn SW, Park KC, Huh CH. Disseminated superficial porokeratosis developed by immunosuppression due to rheumatoid arthritis treatment. J Dermatol. 2009;36(8):466-7. [PubMed]
3. Jang YH, Chun SJ, Kang WH, Lee ES. Eruptive disseminated superficial actinic porokeratosis in an immunocompetent host: is this associated with herpes simplex virus or bacterial infection? J Am Acad Dermatol. 2004;51(6):1018-9. [PubMed]
4. Lee HW, Oh SH, Choi JC, Chang SE, Lee MW, Choi JH, Moon KC, Koh JK. Disseminated superficial porokeratosis in a patient with cholangiocarcinoma. J Am Acad Dermatol. 2006; 54(2):S56-8. [PubMed]
5. Choi KH, Kim TY. A case of inflammatory disseminated superficial porokeratosis in a colon cancer patient. Ann Dermatol. 2009;21(2):150-3. [PubMed]
6. Torres T, Velho GC, Selores M. Disseminated superficial porokeratosis in a patient with cholangiocarcinoma: a paraneoplastic manifestation? An Bras Dermatol. 2010;85(2):229-31. [PubMed]
7. Ueda T, Takeyama Y, Yasuda T, Shinzeki M, Sawa H, Nakajima T, Ajiki T, Fujino Y, Suzuki Y, Kuroda Y. Immunosuppression in patients with severe acute pancreatitis. J Gastroenterol. 2006;41(8):779-84. [PubMed]
8. Venkatarajan S, LeLeux TM, Yang D, Rosen T, Orengo I. Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil. Dermatol Online J. 2010 Dec 15;16(12):10. [PubMed]
© 2011 Dermatology Online Journal